372 related articles for article (PubMed ID: 26359511)
21. Central Role of P2Y6 UDP Receptor in Arteriolar Myogenic Tone.
Kauffenstein G; Tamareille S; Prunier F; Roy C; Ayer A; Toutain B; Billaud M; Isakson BE; Grimaud L; Loufrani L; Rousseau P; Abraham P; Procaccio V; Monyer H; de Wit C; Boeynaems JM; Robaye B; Kwak BR; Henrion D
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1598-606. PubMed ID: 27255725
[TBL] [Abstract][Full Text] [Related]
22. Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes.
Greig AV; Linge C; Terenghi G; McGrouther DA; Burnstock G
J Invest Dermatol; 2003 Jun; 120(6):1007-15. PubMed ID: 12787128
[TBL] [Abstract][Full Text] [Related]
23. Ovariectomy uncovers purinergic receptor activation of endothelin-dependent natriuresis.
Gohar EY; Kasztan M; Becker BK; Speed JS; Pollock DM
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F361-F369. PubMed ID: 28468962
[TBL] [Abstract][Full Text] [Related]
24. Nucleotide signalling during inflammation.
Idzko M; Ferrari D; Eltzschig HK
Nature; 2014 May; 509(7500):310-7. PubMed ID: 24828189
[TBL] [Abstract][Full Text] [Related]
25. Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms.
Beigi RD; Kertesy SB; Aquilina G; Dubyak GR
Br J Pharmacol; 2003 Oct; 140(3):507-19. PubMed ID: 14522842
[TBL] [Abstract][Full Text] [Related]
26. Quantification of ADP and ATP receptor expression in human platelets.
Wang L; Ostberg O; Wihlborg AK; Brogren H; Jern S; Erlinge D
J Thromb Haemost; 2003 Feb; 1(2):330-6. PubMed ID: 12871508
[TBL] [Abstract][Full Text] [Related]
27. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.
Gachet C
Pharmacol Ther; 2005 Nov; 108(2):180-92. PubMed ID: 15955565
[TBL] [Abstract][Full Text] [Related]
28. Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts.
Korcok J; Raimundo LN; Ke HZ; Sims SM; Dixon SJ
J Bone Miner Res; 2004 Apr; 19(4):642-51. PubMed ID: 15005852
[TBL] [Abstract][Full Text] [Related]
29. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
30. P2 receptors for extracellular nucleotides in the central nervous system: role of P2X7 and P2Y₂ receptor interactions in neuroinflammation.
Weisman GA; Camden JM; Peterson TS; Ajit D; Woods LT; Erb L
Mol Neurobiol; 2012 Aug; 46(1):96-113. PubMed ID: 22467178
[TBL] [Abstract][Full Text] [Related]
31. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
Washburn KB; Neary JT
Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
[TBL] [Abstract][Full Text] [Related]
32. Regulation of platelet functions by P2 receptors.
Gachet C
Annu Rev Pharmacol Toxicol; 2006; 46():277-300. PubMed ID: 16402906
[TBL] [Abstract][Full Text] [Related]
33. The Role of CLEC-2 and Its Ligands in Thromboinflammation.
Meng D; Luo M; Liu B
Front Immunol; 2021; 12():688643. PubMed ID: 34177942
[TBL] [Abstract][Full Text] [Related]
34. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets.
Jacobson KA; IJzerman AP; Müller CE
Biochem Pharmacol; 2021 May; 187():114311. PubMed ID: 33130128
[TBL] [Abstract][Full Text] [Related]
35. ATPergic signalling during seizures and epilepsy.
Engel T; Alves M; Sheedy C; Henshall DC
Neuropharmacology; 2016 May; 104():140-53. PubMed ID: 26549853
[TBL] [Abstract][Full Text] [Related]
36. Extracellular ATP Induces Calcium Signaling in Odontoblasts.
Lee BM; Jo H; Park G; Kim YH; Park CK; Jung SJ; Chung G; Oh SB
J Dent Res; 2017 Feb; 96(2):200-207. PubMed ID: 27694154
[TBL] [Abstract][Full Text] [Related]
37. Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation.
del Puerto A; Díaz-Hernández JI; Tapia M; Gomez-Villafuertes R; Benitez MJ; Zhang J; Miras-Portugal MT; Wandosell F; Díaz-Hernández M; Garrido JJ
J Cell Sci; 2012 Jan; 125(Pt 1):176-88. PubMed ID: 22250198
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological and molecular characterization of functional P2 receptors in rat embryonic cardiomyocytes.
Cheung KK; Marques-da-Silva C; Vairo L; dos Santos DS; Goldenberg R; Coutinho-Silva R; Burnstock G
Purinergic Signal; 2015 Mar; 11(1):127-38. PubMed ID: 25510459
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].
Hechler B; Magnenat S; Zighetti ML; Kassack MU; Ullmann H; Cazenave JP; Evans R; Cattaneo M; Gachet C
J Pharmacol Exp Ther; 2005 Jul; 314(1):232-43. PubMed ID: 15792995
[TBL] [Abstract][Full Text] [Related]
40. Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.
Donnelly-Roberts DL; Jarvis MF
Br J Pharmacol; 2007 Jul; 151(5):571-9. PubMed ID: 17471177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
